NASDAQ$MBRX

Moleculin Biotech Inc · Q1 2016 earnings

Q1 2016 earnings · · Investor relations

Headline financials

EPS (adj)

-$4.45

No prior period
Net Income

-$332K

No prior period
Operating Income

-$321K

No prior period
Gross Profit

$0.00

No prior period
R&D Expense

$15K

No prior period

Revenue & EPS history

Moleculin · Revenue · Quarterly

$0

Q1 2026

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

-1.2%

Avg return

Earnings day

-0.8%

Avg return

5 days after

-5.3%

Avg return

30 days after

32%

13 / 41 earnings

Positive

+28.1%

Q4 2019

Best reaction

-20.8%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.8%+9.8%
Q4 2025+0.0%+20.9%+17.5%
Q3 2025-4.4%-3.5%-56.1%
Q2 2025-4.0%-11.7%-46.1%
Q1 2025-8.2%-1.3%-35.3%
Q4 2024-2.8%-3.7%-12.8%
Q3 2024+3.5%+6.3%+3.9%
Q2 2024-5.1%+2.1%+3.4%
Q1 2024+1.9%+6.7%-9.2%
Q4 2023-20.8%-16.4%-29.9%
Q3 2023+1.9%+9.3%-2.4%
Q2 2023-1.3%-7.5%-32.7%
Q1 2023-14.4%-21.7%-23.1%
Q4 2022-1.9%-7.8%-24.0%
Q3 2022+5.1%+6.1%+48.6%
Q2 2022+9.3%+3.7%-12.3%
Q1 2022+1.6%+9.0%+23.0%
Q4 2021-4.4%-1.7%+1.1%
Q3 2021+0.0%-6.5%-5.7%
Q2 2021-3.3%-11.1%-0.3%
Q1 2021-3.8%-2.1%-99.7%
Q4 2020-1.5%-6.6%-11.6%
Q3 2020+2.9%+8.5%+14.1%
Q2 2020-7.4%-5.6%-29.0%
Q1 2020+0.0%+0.0%+11.2%
Q4 2019+28.1%+27.9%+155.9%
Q3 2019+0.9%-0.9%-4.7%
Q2 2019+6.5%+10.2%+13.0%
Q1 2019-0.8%-5.7%-4.9%
Q4 2018+3.8%-1.5%-0.8%
Q3 2018-3.1%+6.1%-3.8%
Q2 2018+0.0%-1.2%+0.0%
Q1 2018-0.6%-0.6%+12.1%
Q4 2017-3.2%-1.1%-0.5%
Q3 2017-0.4%+3.7%+5.6%
Q2 2017-7.7%-11.8%-3.7%
Q1 2017-4.7%-4.9%+0.0%
Q4 2016-12.8%-28.2%-27.4%
Q3 2016-2.4%+1.7%-50.5%
Q2 2016-1.6%-6.7%-1.0%
Q1 2016+2.3%+5.4%+5.2%
Q3 2015

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro